🧬 biology

Dopaminergic signalling through dopamine receptor D2 favours the functional stability of regulatory T cells mitigating gut inflammation and neuroinflammation

This study demonstrates that dopamine receptor D2 (Drd2) signaling in CD4⁺ T cells is essential for maintaining the differentiation, stability, and suppressive function of regulatory T cells, thereby preventing gut inflammation and mitigating dopaminergic neurodegeneration in Parkinson's disease.

Original authors: Jazmín Castro, José Manuel Jiménez, Daniela Elgueta, Ornella Chovar, Valentina Ugalde-Tagle, Nicolás Martínez, Javiera Cea, Alexandra Espinoza, Jacob Mora, Sebastián Valenzuela, Micaela Ricca, Carolin

Published 2026-10-30

📖 5 min read🧠 Deep dive

CC BY 4.0

Original authors: Jazmín Castro, José Manuel Jiménez, Daniela Elgueta, Ornella Chovar, Valentina Ugalde-Tagle, Nicolás Martínez, Javiera Cea, Alexandra Espinoza, Jacob Mora, Sebastián Valenzuela, Micaela Ricca, Carolina Prado, Rodrigo Pacheco

Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). ⚕️ This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer

Parkinson's disease is a condition that slowly robs people of their ability to move, causing tremors, stiffness, and a loss of balance. For decades, scientists have focused on what happens inside the brain, watching as specific nerve cells that produce a chemical called dopamine die off. However, a growing body of evidence suggests the trouble might start much earlier and in a different place: the gut. The connection between the intestines and the brain is a two-way street, and when the immune system in the gut becomes overactive, it can send signals that travel up to the brain, potentially fueling the inflammation that destroys those vital nerve cells. Within the immune system, there are special peacekeeping cells known as regulatory T cells. Their job is to calm down the immune response and prevent it from attacking the body's own tissues. If these peacekeepers fail, inflammation can run wild, damaging both the gut and the brain.

A team of researchers in Chile has now uncovered a specific molecular switch that helps these peacekeeping cells do their job. They discovered that a receptor on the surface of these cells, which listens for the chemical dopamine, is essential for keeping the peacekeepers stable and effective. Without this signal, the peacekeepers lose their identity and stop working, leading to severe inflammation in the gut and accelerated damage to the brain. This finding links the chemical signals of the nervous system directly to the stability of the immune system, offering a new way to understand how the gut and brain influence each other in Parkinson's disease.

To understand how this works, the scientists turned to mice that were engineered to develop a form of Parkinson's disease. They used a virus to introduce a protein called alpha-synuclein into a specific part of the mouse brain known as the substantia nigra. In humans and mice, the buildup of this protein is a hallmark of Parkinson's and triggers an immune response that kills off dopamine-producing neurons. The researchers wanted to see what would happen if they removed the dopamine receptor, known as Drd2, from the immune cells. They created two groups of mice: one group lacked this receptor on their CD4 T cells, a type of white blood cell that includes the regulatory peacekeepers, and another group lacked it on their CD8 T cells, which are more like the immune system's soldiers.

The results were striking and specific. The mice missing the receptor on their CD4 T cells suffered much worse outcomes. They lost more of their dopamine-producing neurons and showed significant trouble with movement, struggling to walk across narrow beams. In contrast, the mice missing the receptor only on their CD8 T cells remained healthy and moved normally. This told the researchers that the problem was not with the immune system in general, but specifically with the CD4 T cells. When they looked closer at the brains of the sick mice, they found that these animals had more immune cells invading the brain and that the brain's own immune cells, called microglia, were in a highly aggressive state, ready to cause damage.

Digging deeper, the team found that the CD4 T cells in the sick mice were failing to produce enough regulatory peacekeepers. In a healthy immune system, these cells are generated to keep inflammation in check. But without the dopamine signal, the immune system failed to create enough of them. Even worse, the peacekeepers that did exist were unstable. In laboratory tests, when the researchers activated these cells, those lacking the dopamine receptor quickly lost their ability to suppress inflammation. Instead of staying calm, they began to produce chemicals that drive inflammation, essentially turning from peacekeepers into aggressors. This change happened even though the cells were still alive; they simply forgot how to be regulatory.

To see if this instability mattered in the gut, the researchers moved to a model of intestinal inflammation. They induced colitis in mice, a condition similar to inflammatory bowel disease, and transferred regulatory T cells into them. Some mice received healthy peacekeepers, while others received cells that lacked the dopamine receptor. The mice with healthy cells recovered well, losing less weight and suffering less damage to their intestines. However, the mice that received the defective cells did not improve. The defective cells managed to travel to the inflamed gut just fine, but once they arrived, they lost their regulatory identity and could not stop the inflammation. This confirmed that the dopamine receptor is not needed for the cells to get to the site of trouble, but it is absolutely critical for them to stay calm and do their job once they are there.

The study suggests that dopamine, the same chemical that is depleted in the brains of people with Parkinson's, plays a vital role in teaching immune cells how to behave. When this signal is missing, the immune system loses its ability to regulate itself, leading to a cycle of inflammation that damages the gut and accelerates the loss of nerve cells in the brain. The researchers found that this effect is specific to the regulatory T cells and does not seem to depend on other types of immune cells. While the exact internal machinery of how the receptor keeps the cells stable is still being investigated, the evidence is clear: without this dopamine signal, the immune system's peacekeepers become unreliable, and the body pays the price in both the gut and the brain. This work highlights a direct line of communication between the nervous system and the immune system, suggesting that maintaining this connection could be key to protecting the body from the dual assault of gut inflammation and neurodegeneration.

Technical Summary: Dopaminergic Signalling through Dopamine Receptor D2 Favors the Functional Stability of Regulatory T Cells

Problem Statement
Parkinson's disease (PD) is characterized by progressive dopaminergic neurodegeneration, $\alpha$ -synuclein ( $\alpha$ Syn) accumulation, and chronic neuroinflammation. While the role of innate immunity in PD is established, the mechanisms controlling adaptive immune responses, specifically Regulatory T (Treg) cells, remain incompletely understood. Tregs are critical for restraining inflammation in both the central nervous system (CNS) and the intestine, yet the specific molecular pathways governing their stability and function during PD are unclear. Previous research has indicated that dopamine receptor D3 (Drd3) signaling promotes pro-inflammatory T-cell responses, whereas D2 (Drd2) signaling appears to have anti-inflammatory effects. However, the specific contribution of Drd2 signaling in T-cells to Treg differentiation, phenotypic stability, and the mitigation of both gut and neuroinflammation in an $\alpha$ Syn-driven context had not been fully elucidated.

Methodology
The study utilized a combination of conditional knockout mouse models, viral vector-mediated neurodegeneration, and colitis models to dissect the role of Drd2 in T-cell subsets.

Mouse Models: The researchers employed Drd2 floxed (Drd2^f/f^) mice crossed with CD4^Cre^ and CD8^Cre^ mice to generate CD4^Cre^Drd2^f/f^ (Drd2 deficient in both CD4+ and CD8+ T-cells due to thymic recombination) and CD8^Cre^Drd2^f/f^ (Drd2 deficient only in CD8+ T-cells) strains. Foxp3^GFP^ reporter mice were used to track Treg differentiation and stability.
PD Model: Neurodegeneration was induced via unilateral stereotaxic injection of adeno-associated viral vectors encoding human $\alpha$ -synuclein (AAV- $\alpha$ Syn) into the substantia nigra (SN) of mice. This model mimics the antigen-specific T-cell response observed in human PD.
Colitis Model: Intestinal inflammation was induced using dextran sodium sulphate (DSS) in drinking water.
In Vitro Assays: Naïve CD4+ T-cells were differentiated into induced Tregs (iTregs) to assess differentiation capacity. Activated Tregs were cultured with or without dopamine to evaluate phenotypic stability (Foxp3 expression vs. IL-17/IFN- $\gamma$ production).
Adoptive Transfer: Wild-type (WT) and Drd2-deficient Tregs were transferred into DSS-treated mice to assess suppressive function and phenotypic maintenance in the colonic lamina propria (cLP) in vivo.
Analysis: Techniques included flow cytometry for T-cell subset frequencies and cytokine production, immunohistochemistry/immunofluorescence for dopaminergic neuronal density (Tyrosine Hydroxylase, TH), microglial activation (Iba1, TREM2), and T-cell infiltration (CD4, CD8). Motor function was assessed via the beam test.

Key Results

CD4+ T-cell Specificity: In the AAV- $\alpha$ Syn model, CD4^Cre^Drd2^f/f^ mice exhibited significantly exacerbated dopaminergic neuronal loss in the SN and severe motor impairment compared to controls. In contrast, CD8^Cre^Drd2^f/f^ mice (lacking Drd2 only in CD8+ cells) showed no such phenotype, indicating that Drd2 signaling in CD4+ T-cells is the critical protective factor.
Neuroinflammation and Infiltration: Drd2 deficiency in CD4+ T-cells led to increased infiltration of CD4+ T-cells into the SN and a shift in microglia toward a damage-responsive phenotype (increased TREM2 expression), without affecting CD8+ T-cell infiltration.
Treg Generation and Stability: In CD4^Cre^Drd2^f/f^ mice, the frequency of splenic Treg cells was selectively reduced, while pro-inflammatory subsets (Th1, Th17, TNF- $\alpha$ $α$ ) remained unchanged.
- In vitro: Drd2-deficient naïve CD4+ T-cells showed impaired differentiation into Foxp3+ Tregs and reduced TGF- $\beta$ production.
- Stability: Upon activation, Drd2-deficient Tregs exhibited decreased Foxp3 expression and increased production of IL-17 and IFN- $\gamma$ , despite normal cell viability. This suggests a loss of phenotypic stability rather than cell death.
Gut Inflammation and Suppressive Function: In the DSS colitis model, adoptively transferred Drd2-deficient Tregs failed to attenuate body weight loss or colon shortening compared to WT Tregs. While the recruitment of Drd2-deficient Tregs to the colonic lamina propria was preserved, these cells showed a marked reduction in Foxp3 expression, confirming that Drd2 is required for maintaining Treg identity and suppressive function in inflamed tissue.

Key Contributions

Specificity of Drd2 in CD4+ T-cells: The study distinguishes the roles of Drd2 in CD4+ versus CD8+ T-cells, demonstrating that the protective effect against $\alpha$ Syn-induced neurodegeneration is mediated specifically by Drd2 signaling in the CD4+ compartment.
Mechanism of Treg Instability: The research identifies Drd2 signaling as a critical regulator of Treg phenotypic stability. It demonstrates that in the absence of Drd2, Tregs lose their Foxp3 expression and acquire pro-inflammatory cytokine profiles (IL-17, IFN- $\gamma$ ) under inflammatory conditions, rather than simply dying or failing to differentiate.
Gut-Brain Axis Connection: By linking Drd2-dependent Treg stability in the gut to the mitigation of neuroinflammation, the paper provides mechanistic evidence supporting the gut-brain axis in PD pathogenesis, suggesting that intestinal immune dysregulation can exacerbate CNS pathology.

Significance
The paper establishes Drd2 signaling in CD4+ T-cells as a fundamental regulator of immune homeostasis that limits $\alpha$ Syn-associated dopaminergic neurodegeneration and motor dysfunction. By defining Drd2 as essential for both the differentiation and the functional stability of Tregs, the study highlights a previously underappreciated connection between dopaminergic immunoregulation and the gut-brain axis. The findings suggest that the loss of Treg stability due to impaired Drd2 signaling contributes to the progression of both intestinal inflammation and neurodegeneration. Consequently, Drd2 is proposed as a potential therapeutic target for strategies aimed at restoring immune tolerance in Parkinson's disease and other inflammation-associated disorders, particularly through approaches that stabilize Treg function.

More like this